{"content":"<li class=\"n-box-item date-title\" data-end=\"1502337599\" data-start=\"1502251200\" data-txt=\"Monday, December 23, 2019\">Wednesday, August  9, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3287924\" data-ts=\"1502322851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287924-fox-news-tops-ratings-again-game-of-thrones-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox News tops ratings again; &#39;Game of Thrones&#39; at new high</a></h4><ul>   <li>Fox News (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.7%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-0.5%</font>) <a href=\"http://www.multichannel.com/news/content/fox-news-game-thrones-stay-hot-weekly-cable-ratings-race/414506?utm_source=dlvr.it&amp;utm_medium=twitter\" target=\"_blank\">topped the cable prime-time ratings</a> for the 11th straight week, while HBO's (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+0.1%</font>) flagship series hit another new high.</li>    <li>Sunday's <i>Game of Thrones</i> was far and away the week's most-viewed program, and it hit an all-time series viewership high of 10.2M. A distant second place came from <i>WWE Monday Night Raw</i> on USA Network (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1.8%</font>), with 3.2M viewers.</li>    <li>Fox News averaged 2.1M viewers in prime-time and also again bested the children's networks on a total-day basis, Nielsen says.</li>    <li>Behind Fox News: MSNBC (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) with 1.7M viewers; a third-place tie between USA Network and HGTV (<a href=\"http://seekingalpha.com/symbol/SNI\" target=\"_blank\">SNI</a> <font color='red'>-0.6%</font>) with 1.4M; and TBS (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) with 1.2M.</li>    <li>In the 18-49 demographic, USA Network was tops in prime-time, and Adult Swim (<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) on a 24-hour basis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287924\" data-linked=\"Fox News tops ratings again; &#39;Game of Thrones&#39; at new high\" data-tweet=\"$FOX $FOX $FOXA - Fox News tops ratings again; &#39;Game of Thrones&#39; at new high https://seekingalpha.com/news/3287924-fox-news-tops-ratings-again-game-of-thrones-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3287924-fox-news-tops-ratings-again-game-of-thrones-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287921\" data-ts=\"1502321315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTES\" target=\"_blank\">NTES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287921-neteaseminus-3-profits-fall-short-despite-strong-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetEase -3% as profits fall short despite strong revenue growth</a></h4><ul>   <li>NetEase (<a href=\"http://seekingalpha.com/symbol/NTES\" target=\"_blank\">NTES</a> <font color='green'>+1.9%</font>) is <font color='red'>off 3%</font> in after-hours trading following a miss on profits in Q2 despite revenues that grew 47% and soundly beat the Street.</li>    <li>Diluted EPADS on a non-GAAP basis came to $3.86, light of expectations for $4.02. Net income rose 7.8% Y/Y.</li>    <li>\"While e-commerce is becoming an increasingly important revenue contributor\" -- it rose nearly 69% -- \"our self-developed mobile games remain our primary growth engine,\" says CEO William Ding.</li>    <li>Revenue by segment: Online game services, 9.43B yuan (about $1.39B, up 46.5% in renminbi terms); Advertising services, 595.6M yuan ($87.86M, up 12.1%); E-mail, e-commerce and others, 3.35B yuan ($494.2M, up 68.9%).</li>    <li>Gross profit by segment: Online game services, 5.95B yuan ($878.4M); Advertising services, 402.6M yuan ($59.4M); E-mail, e-commerce and others, 379.27M yuan ($55.9M).</li>    <li><a href=\"http://ir.netease.com/\" target=\"_blank\">Conference call</a> to come at 9 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16912185-netease-reports-second-quarter-2017-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287921\" data-linked=\"NetEase -3% as profits fall short despite strong revenue growth\" data-tweet=\"$NTES - NetEase -3% as profits fall short despite strong revenue growth https://seekingalpha.com/news/3287921-neteaseminus-3-profits-fall-short-despite-strong-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3287921-neteaseminus-3-profits-fall-short-despite-strong-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287920\" data-ts=\"1502320439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEO\" target=\"_blank\">TEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287920-telecom-argentina-sees-profits-double-solid-mobile-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Argentina sees profits double with solid mobile growth</a></h4><ul>   <li>Telecom Argentina (<a href=\"http://seekingalpha.com/symbol/TEO\" target=\"_blank\">TEO</a> <font color='red'>-1.8%</font>) <a href=\"https://seekingalpha.com/pr/16912123-telecom-argentina-s-announces-consolidated-six-month-period-1h17-second-quarter-results\" target=\"_blank\">doubled its net income</a> all while unloading debt in the first half.</li>    <li>Operating income rose 57%; net income gains were influenced by a growing EBITDA, better financial results and by higher depreciation/amortization.</li>    <li>Mobile clients came to 22M. Telecom Personal reached 19.5M subscribers in Argentina (postpaid clients at 33% of the base); in Paraguay, Nucleo's subscriber base hit 2.5M clients.</li>    <li>Mobile ARPU in Argentina rose 27.5%, to 135.30 pesos a month.</li>    <li>Telecom reached 1.7M ADSL accesses as of June 30 (44.9% of Telecom's fixed lines in service). ADSL ARPU reached 344 pesos, up 35% Y/Y; Monthly churn fell to 1.4% from 1.5%.</li>    <li>Revenue breakout: Mobile services, 21.2B pesos (up 15.5%); Fixed services, 9.36B pesos (up 32.6%).</li>    <li>Capex was 4B pesos (down 10.5%); 1.81B to fixed services and 2.2B to mobile.</li>    <li><a href=\"https://seekingalpha.com/pr/16912123-telecom-argentina-s-announces-consolidated-six-month-period-1h17-second-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287920\" data-linked=\"Telecom Argentina sees profits double with solid mobile growth\" data-tweet=\"$TEO - Telecom Argentina sees profits double with solid mobile growth https://seekingalpha.com/news/3287920-telecom-argentina-sees-profits-double-solid-mobile-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3287920-telecom-argentina-sees-profits-double-solid-mobile-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287916\" data-ts=\"1502318909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCHC\" target=\"_blank\">HCHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287916-hc2-holdingsminus-2_2-after-swinging-to-q2-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HC2 Holdings -2.2% after swinging to Q2 loss</a></h4><ul>   <li>HC2 Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) is <font color='red'>off 2.2%</font> in light postmarket trade after missing on top and bottom lines with its <a href=\"https://seekingalpha.com/news/3287754-hc2-holdings-misses-0_26-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li>    <li>The company swung to a net loss of $18.7M from a year-ago gain of $0.9M.</li>    <li>EBITDA for its \"core\" subsidiaries was $17.9M, down from a year-ago $27.1M; total EBITDA excluding Insurance was $4.6M, vs. a year-ago $15.2M.</li>    <li>Revenue growth was driven by gains in Construction, Marine Services, Energy, and Insurance, HC2 says.</li>    <li>Revenue breakout: Services revenue, $196.97M (down 0.2%); Sales revenue, $143.4M (up 14%); Life, accident and health earned net premiums, $20.2M (up 1%); Net investment income, $16.9M (up 23.6%); Net realized gains on investments, $1.1M (down 54.7%).</li>    <li>Cash, equivalents and investments (again excluding Insurance) came to $1.7B; consolidated cash was $104.6M.</li>    <li><a href=\"https://seekingalpha.com/pr/16911986-hc2-holdings-reports-second-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287916\" data-linked=\"HC2 Holdings -2.2% after swinging to Q2 loss\" data-tweet=\"$HCHC - HC2 Holdings -2.2% after swinging to Q2 loss https://seekingalpha.com/news/3287916-hc2-holdingsminus-2_2-after-swinging-to-q2-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3287916-hc2-holdingsminus-2_2-after-swinging-to-q2-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287913\" data-ts=\"1502317307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDSN\" target=\"_blank\">HDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287913-hudson-techplus-22-on-q2-beat-220m-purchase-of-industrial-gases-supplier\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson Tech +22% on Q2 beat, $220M purchase of industrial gases supplier</a></h4><ul>     <li>Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a>) <font color='green'>+22.5%</font>&nbsp;AH after beating analyst expectations for <a href=\"https://seekingalpha.com/news/3287720-hudson-tech-beats-0_04-beats-revenue\" target=\"_blank\">Q2 earnings</a> and revenues, which rose 51%&nbsp;Y/Y to a company record $52.2M.</li>     <li>Q2 gross margin was 33% compared to 30% in the prior-year period, benefitting from incremental increases in the average selling price for R-22 refrigerant as well as a temporary increase in pricing for HFC refrigerants, and gross margin for H1 rose to 33% from 29% in the first six months of 2016.</li>     <li>HDSN also <a href=\"https://seekingalpha.com/pr/16911865-hudson-technologies-acquire-airgas-refrigerants-inc\" target=\"_blank\">agrees to acquire</a> Airgas subsidiary Airgas-Refrigerants Inc., a leading U.S. supplier of industrial gases, for ~$220M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287913\" data-linked=\"Hudson Tech +22% on Q2 beat, $220M purchase of industrial gases supplier\" data-tweet=\"$HDSN - Hudson Tech +22% on Q2 beat, $220M purchase of industrial gases supplier https://seekingalpha.com/news/3287913-hudson-techplus-22-on-q2-beat-220m-purchase-of-industrial-gases-supplier?source=tweet\" data-url=\"https://seekingalpha.com/news/3287913-hudson-techplus-22-on-q2-beat-220m-purchase-of-industrial-gases-supplier\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287886\" data-ts=\"1502315136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPA\" target=\"_blank\">CPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287886-copa-holdings-misses-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copa Holdings misses by $0.01, beats on revenue</a></h4><ul><li>Copa Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CPA' title='Copa Holdings, S.A.'>CPA</a>): Q2 EPS of $1.48 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $578.1M (+16.9% Y/Y) <font color='green'>beats by $13.98M</font>.</li><li>Shares <font color='green'>+2.2%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16912142-copa-holdings-reports-net-income-63_0-million-eps-1_49-second-quarter-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287886\" data-linked=\"Copa Holdings misses by $0.01, beats on revenue\" data-tweet=\"$CPA - Copa Holdings misses by $0.01, beats on revenue https://seekingalpha.com/news/3287886-copa-holdings-misses-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287886-copa-holdings-misses-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287885\" data-ts=\"1502315075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDSA\" target=\"_blank\">IDSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287885-industrial-services-of-america-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Industrial Services of America reports Q2 results</a></h4><ul><li>Industrial Services of America (NASDAQ:<a href='https://seekingalpha.com/symbol/IDSA' title='Industrial Services of America, Inc.'>IDSA</a>): Q2 EPS of -$0.05</li><li>Revenue of $13.6M (+34.4% Y/Y)</li><li>Shares <font color='green'>+40%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16911997-industrial-services-america-inc-announces-substantial-improvement-financial-performance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287885\" data-linked=\"Industrial Services of America reports Q2 results\" data-tweet=\"$IDSA - Industrial Services of America reports Q2 results https://seekingalpha.com/news/3287885-industrial-services-of-america-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287885-industrial-services-of-america-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287880\" data-ts=\"1502314872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287880-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='green'>+14.6%</font>. <a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/PLNT' title='Planet Fitness'>PLNT</a> <font color='green'>+4.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-30.0%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='red'>-22.1%</font>. <a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-19.7%</font>. <a href='https://seekingalpha.com/symbol/DOOR' title='Masonite International Corporation'>DOOR</a> <font color='red'>-14.7%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-14.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287880\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ASYS $LYV $SGMO - After Hours Gainers / Losers https://seekingalpha.com/news/3287880-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3287880-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287879\" data-ts=\"1502314805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROX\" target=\"_blank\">ROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287879-castle-brands-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle Brands reports Q1 results</a></h4><ul><li>Castle Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a>): Q1 EPS of -$0.01</li><li>Revenue of $20.9M (+24.4% Y/Y)</li><li>Shares <font color='green'>+1.1%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16912054-castle-brands-announces-fiscal-2018-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287879\" data-linked=\"Castle Brands reports Q1 results\" data-tweet=\"$ROX - Castle Brands reports Q1 results https://seekingalpha.com/news/3287879-castle-brands-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287879-castle-brands-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287863\" data-ts=\"1502313955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287863-heron-therapeutics-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics beats by $0.12, beats on revenue</a></h4><ul><li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>): Q2 EPS of -$0.80 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $8.5M <font color='green'>beats by $2.96M</font>.</li><li>Shares <font color='green'>+4.5%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16911995-heron-therapeutics-reports-financial-results-three-six-months-ended-june-30-2017-recent'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287863\" data-linked=\"Heron Therapeutics beats by $0.12, beats on revenue\" data-tweet=\"$HRTX - Heron Therapeutics beats by $0.12, beats on revenue https://seekingalpha.com/news/3287863-heron-therapeutics-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287863-heron-therapeutics-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287856\" data-ts=\"1502313748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLNT\" target=\"_blank\">FLNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287856-cogint-beats-revenue-expectations-for-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cogint beats revenue expectations for Q2</a></h4><ul>   <li>Cogint (<a href=\"http://seekingalpha.com/symbol/COGT\" target=\"_blank\">COGT</a> <font color='red'>-1.1%</font>) is <font color='green'>up 3.3%</font> so far in thin after-hours trading following <a href=\"https://seekingalpha.com/news/3287717-cogint-misses-0_20-beats-revenue\" target=\"_blank\">Q2 earnings</a> where revenues rose nearly 30% and underlying profits were up by more than 50%.</li>    <li>EBITDA rose 54%, to $4.8M. Net loss was $20.4M, including nonrecurring costs of $10M.</li>    <li>Revenue breakout: Information Services, $18.6M (up 39%); Performance Marketing, $34.4M (up 24%).</li>    <li>More than 50 customers are spending in excess of $1M on an annualized basis, the company says.</li>    <li><a href=\"https://seekingalpha.com/pr/16911876-cogint-announces-2017-second-quarter-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287856\" data-linked=\"Cogint beats revenue expectations for Q2\" data-tweet=\"$FLNT - Cogint beats revenue expectations for Q2 https://seekingalpha.com/news/3287856-cogint-beats-revenue-expectations-for-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3287856-cogint-beats-revenue-expectations-for-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287854\" data-ts=\"1502313637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAAS\" target=\"_blank\">PAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287854-pan-american-silver-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pan American Silver beats by $0.05, beats on revenue</a></h4><ul><li>Pan American Silver (NASDAQ:<a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a>): Q2 EPS of $0.15 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $201.3M (+4.7% Y/Y) <font color='green'>beats by $12.83M</font>.</li><li>Shares <font color='green'>+2.1%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16912109-pan-american-silver-announces-unaudited-net-earnings-0_23-per-share-q2-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287854\" data-linked=\"Pan American Silver beats by $0.05, beats on revenue\" data-tweet=\"$PAAS - Pan American Silver beats by $0.05, beats on revenue https://seekingalpha.com/news/3287854-pan-american-silver-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287854-pan-american-silver-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287847\" data-ts=\"1502313140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287847-fortress-biotech-misses-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress Biotech misses by $0.13, beats on revenue</a></h4><ul><li>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>): Q2 EPS of -$0.43 <font color='red'>misses by $0.13</font>.</li><li>Revenue of $50.7M (+2173.5% Y/Y) <font color='green'>beats by $6.6M</font>.</li><li>Shares <font color='green'>+17.28%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16911921-fortress-biotech-reports-second-quarter-2017-financial-results-recent-corporate-highlights'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287847\" data-linked=\"Fortress Biotech misses by $0.13, beats on revenue\" data-tweet=\"$FBIO - Fortress Biotech misses by $0.13, beats on revenue https://seekingalpha.com/news/3287847-fortress-biotech-misses-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287847-fortress-biotech-misses-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287845\" data-ts=\"1502313084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPRT\" target=\"_blank\">SPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287845-support-com-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Support.com reports Q2 results</a></h4><ul><li>Support.com (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRT' title='Support.com, Inc.'>SPRT</a>): Q2 EPS of -$0.01</li><li>Revenue of $14.5M (-2.7% Y/Y)</li><li>Shares <font color='green'>+3.4%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16911879-support-com-reports-second-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287845\" data-linked=\"Support.com reports Q2 results\" data-tweet=\"$SPRT - Support.com reports Q2 results https://seekingalpha.com/news/3287845-support-com-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287845-support-com-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287839\" data-ts=\"1502312789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYRS\" target=\"_blank\">SYRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287839-syros-pharmaceuticals-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syros Pharmaceuticals reports Q2 results</a></h4><ul><li>Syros Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals'>SYRS</a>): Q2 EPS of -$0.52</li><li>Cash and equivalents  of $91.5M.</li><li><a href=\"https://seekingalpha.com/pr/16911866-syros-reports-second-quarter-2017-financial-results-highlights-accomplishments-upcoming\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287839\" data-linked=\"Syros Pharmaceuticals reports Q2 results\" data-tweet=\"$SYRS - Syros Pharmaceuticals reports Q2 results https://seekingalpha.com/news/3287839-syros-pharmaceuticals-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287839-syros-pharmaceuticals-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287836\" data-ts=\"1502312675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIO\" target=\"_blank\">ABIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287836-arca-bios-mid-stage-study-of-gencaro-in-atrial-fibrillation-to-continue-planned-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARCA bio&#39;s mid-stage study of Gencaro in atrial fibrillation to continue as planned; shares ahead 9% after hours</a></h4><ul><li>Thinly traded nano cap ARCA biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIO' title='ARCA biopharma, Inc.'>ABIO</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;on increased volume on the <a href=\"https://seekingalpha.com/pr/16912027-arca-biopharma-announces-genetic-af-data-safety-monitoring-board-recommendation-complete\" target=\"_blank\">news </a>that the independent Data and Safety Monitoring Board &#40;DSMB&#41; has completed its pre-planned interim analysis of the company's Phase 2b clinical trial, GENETIC-AF, evaluating Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (irregular heartbeat).</li><li>The DSMB recommends that the study continue unmodified.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2422586-arca-bios-gencaro-fast-trackd-for-prevention-of-atrial-fibrillation\" target=\"_blank\">ARCA bio's Gencaro Fast Track'd for prevention of atrial fibrillation</a> (April 13, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287836\" data-linked=\"ARCA bio&#39;s mid-stage study of Gencaro in atrial fibrillation to continue as planned; shares ahead 9% after hours\" data-tweet=\"$ABIO - ARCA bio&#39;s mid-stage study of Gencaro in atrial fibrillation to continue as planned; shares ahead 9% after hours https://seekingalpha.com/news/3287836-arca-bios-mid-stage-study-of-gencaro-in-atrial-fibrillation-to-continue-planned-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3287836-arca-bios-mid-stage-study-of-gencaro-in-atrial-fibrillation-to-continue-planned-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287834\" data-ts=\"1502312588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287834-cyclacel-pharmaceuticals-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyclacel Pharmaceuticals reports Q2 results</a></h4><ul><li>Cyclacel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a>): Q2 EPS of -$0.50</li><li>Revenue of $0.22M.</li><li>Cash and equivalents of $13.6M.</li><li>Shares <font color='green'>+1.8%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/16911907-cyclacel-pharmaceuticals-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287834\" data-linked=\"Cyclacel Pharmaceuticals reports Q2 results\" data-tweet=\"$CYCC - Cyclacel Pharmaceuticals reports Q2 results https://seekingalpha.com/news/3287834-cyclacel-pharmaceuticals-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287834-cyclacel-pharmaceuticals-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287823\" data-ts=\"1502312345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287823-magicjack-vocaltec-q2-loss-not-bad-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagicJack VocalTec Q2 loss not as bad as expected</a></h4><ul>   <li>MagicJack VocalTec (<a href=\"http://seekingalpha.com/symbol/CALL\" target=\"_blank\">CALL</a> <font color='green'>+3.2%</font>) beat expectations on top and bottom lines with its <a href=\"https://seekingalpha.com/news/3287806-magicjack-vocaltec-communications-beats-0_08-beats-revenue\" target=\"_blank\">Q2 earnings</a>, despite swinging to a GAAP loss with a double-digit revenue decline.</li>    <li>The company posted a net loss on a GAAP basis of $1.6M, vs. a year-ago gain of $2.82M. That included $2.6M in tax-related items (including expiration of stock options) and other costs for tax and legal settlements.</li>    <li>EBITDA came to $4.4M.</li>    <li>MagicJack activated 87,000 subscribers in the quarter; total active subs came to 2.04M.</li>    <li>Average monthly churn was 2.1%.</li>    <li>Cash and equivalents at quarter's end came to $47M, against no debt.</li>    <li>Shares are flat in after-hours trading so far.</li>    <li><a href=\"https://seekingalpha.com/pr/16912045-magicjack-reports-second-quarter-2017-financial-results\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16912045-magicjack-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287823\" data-linked=\"MagicJack VocalTec Q2 loss not as bad as expected\" data-tweet=\"$CALL - MagicJack VocalTec Q2 loss not as bad as expected https://seekingalpha.com/news/3287823-magicjack-vocaltec-q2-loss-not-bad-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3287823-magicjack-vocaltec-q2-loss-not-bad-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287820\" data-ts=\"1502312177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287820-rgs-energy-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RGS Energy reports Q2 results</a></h4><ul><li>RGS Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a>): Q2 EPS of -$0.53</li><li>Revenue of $3.11M (-38.0% Y/Y)</li><li>Shares <font color='green'>+4.8%</font>.</li><li><a href='https://seekingalpha.com/pr/16911977-rgs-energy-reports-second-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287820\" data-linked=\"RGS Energy reports Q2 results\" data-tweet=\"$RGSE - RGS Energy reports Q2 results https://seekingalpha.com/news/3287820-rgs-energy-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287820-rgs-energy-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287817\" data-ts=\"1502311992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZFGN\" target=\"_blank\">ZFGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287817-zafgen-files-for-150m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zafgen files for $150M mixed shelf offering</a></h4><ul><li>Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) files an <a href=\"https://www.sec.gov/Archives/edgar/data/1374690/000119312517252848/d412284ds3.htm\" target=\"_blank\">S-3</a> for a $150M offering of common stock, preferred stock, debt securities, warrants and/or units.</li><li>Net proceeds will be used for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287817\" data-linked=\"Zafgen files for $150M mixed shelf offering\" data-tweet=\"$ZFGN - Zafgen files for $150M mixed shelf offering https://seekingalpha.com/news/3287817-zafgen-files-for-150m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3287817-zafgen-files-for-150m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287811\" data-ts=\"1502311633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287811-portola-q2-loss-widens-u-s-bevyxxa-launch-on-deck\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Q2 loss widens; U.S. Bevyxxa launch on deck</a></h4><ul><li>Portola Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>) <a href=\"https://seekingalpha.com/pr/16912008-portola-pharmaceuticals-reports-second-quarter-2017-financial-results-provides-corporate\" target=\"_blank\">Q2 results</a> ($M): Collaboration/License Revenue: 3.8 (-9.5%); Net Loss: (69.7) (-21.6%); Loss/Share: (1.22) (-19.6%).</li><li>U.S. launch of Bevyxxa (betrixaban) to commence in September - November time frame.</li><li>CHMP opinion in Europe expected in Q4/early 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287811\" data-linked=\"Portola Q2 loss widens; U.S. Bevyxxa launch on deck\" data-tweet=\"$PTLA - Portola Q2 loss widens; U.S. Bevyxxa launch on deck https://seekingalpha.com/news/3287811-portola-q2-loss-widens-u-s-bevyxxa-launch-on-deck?source=tweet\" data-url=\"https://seekingalpha.com/news/3287811-portola-q2-loss-widens-u-s-bevyxxa-launch-on-deck\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287807\" data-ts=\"1502311312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287807-cb-and-iminus-22-after-big-q2-loss-dividend-suspension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I -22% after big Q2 loss, dividend suspension</a></h4><ul>     <li>Chicago Bridge &amp;&nbsp;Iron (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-0.5%</font>) <font color='red'>-22.1%</font>&nbsp;AH after reporting a massive <a href=\"https://seekingalpha.com/news/3287747-chicago-bridge-and-iron-misses-3_85-misses-revenue\" target=\"_blank\">Q2 loss</a> on 40% lower revenue than the year-ago quarter; it is suspending its dividend as part of a cost reduction program.</li>     <li>CBI says new awards in Q2 totaled $1.1B compared with $1.3B in the year-ago quarter; backlog as of June 30 was $13.6B vs. $14.7B at the same time last year.</li>     <li>Q2 revenue in the engineering and construction unit was $702M, less than half of the $1.5B in the year-ago quarter, due to the wind-down of a large cost-reimbursable LNG mechanical erection project  in the Asia-Pacific region and lower revenue on two U.S. LNG projects.</li>     <li>CBI expects H2 revenue of $3.7B-$4B and EPS of $1.00-$1.25.</li>     <li>CBI also is pursuing a sale of its technology business, and plans to use the proceeds from a sale to strengthen its finances by eliminating most of its debt and reinvesting in its E&amp;C and fabrication services businesses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287807\" data-linked=\"CB&amp;I -22% after big Q2 loss, dividend suspension\" data-tweet=\"$CBI - CB&amp;I -22% after big Q2 loss, dividend suspension https://seekingalpha.com/news/3287807-cb-and-iminus-22-after-big-q2-loss-dividend-suspension?source=tweet\" data-url=\"https://seekingalpha.com/news/3287807-cb-and-iminus-22-after-big-q2-loss-dividend-suspension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287778\" data-ts=\"1502310493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287778-live-nation-entertainment-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Nation Entertainment beats by $0.10, beats on revenue</a></h4><ul><li>Live Nation Entertainment (NYSE:<a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a>): Q2 EPS of $0.29 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $2.82B (+29.4% Y/Y) <font color='green'>beats by $450M</font>.</li><li>Shares <font color='green'>+6.67%</font>.</li><li><a href='https://seekingalpha.com/pr/16912001-live-nation-entertainment-reports-second-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287778\" data-linked=\"Live Nation Entertainment beats by $0.10, beats on revenue\" data-tweet=\"$LYV - Live Nation Entertainment beats by $0.10, beats on revenue https://seekingalpha.com/news/3287778-live-nation-entertainment-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287778-live-nation-entertainment-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287745\" data-ts=\"1502309872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287745-form-holdings-narrows-loss-xpresspa-gooses-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FORM Holdings narrows loss as XpresSpa gooses revenues</a></h4><ul>   <li>FORM Holdings (<a href=\"http://seekingalpha.com/symbol/FH\" target=\"_blank\">FH</a> <font color='green'>+11.5%</font>) <a href=\"https://seekingalpha.com/news/3287706-form-holdings-reports-q2-results\" target=\"_blank\">missed profit expectations</a> despite revenues that jumped 44% thanks to acquiring XpresSpa and Excalibur.</li>    <li>The company narrowed its operating loss to $5.1M from a year-ago $9.7M, vs. an expected loss of $3.57M. That loss included $0.3M in merger integration costs and $0.7M in stock-based compensation expense.</li>    <li>Current assets were $15.9M, with $8M in cash against long-term debt of $6.5M.</li>    <li>It's reaffirming full-year guidance for more than $70M in revenue, in line with expectations; $50M is expected to come from its Wellness segment (XpresSpa), and $20M from Technology (Group Mobile).</li>    <li>It also sees 2018 revenue of $60M from Wellness (up 20% from 2017).</li>    <li><a href=\"http://www.formholdings.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16911887-form-holdings-reports-second-quarter-2017-results-provides-business-update\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287745\" data-linked=\"FORM Holdings narrows loss as XpresSpa gooses revenues\" data-tweet=\"$XSPA - FORM Holdings narrows loss as XpresSpa gooses revenues https://seekingalpha.com/news/3287745-form-holdings-narrows-loss-xpresspa-gooses-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3287745-form-holdings-narrows-loss-xpresspa-gooses-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287736\" data-ts=\"1502309788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASYS\" target=\"_blank\">ASYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287736-amtech-beats-0_31-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amtech beats by $0.31, beats on revenue</a></h4><ul><li>Amtech (NASDAQ:<a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>): Q3 EPS of $0.25 <font color='green'>beats by $0.31</font>.</li><li>Revenue of $47.76M (+43.3% Y/Y) <font color='green'>beats by $7.36M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/16911899-amtech-reports-significantly-higher-revenue-earnings-q3-fiscal-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287736\" data-linked=\"Amtech beats by $0.31, beats on revenue\" data-tweet=\"$ASYS - Amtech beats by $0.31, beats on revenue https://seekingalpha.com/news/3287736-amtech-beats-0_31-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287736-amtech-beats-0_31-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287733\" data-ts=\"1502309738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLNT\" target=\"_blank\">PLNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287733-strong-sales-growth-for-planet-fitness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong sales growth for Planet Fitness</a></h4><ul> <li>Same-store sales increased 9% for Planet Fitness (NYSE:<a href='https://seekingalpha.com/symbol/PLNT' title='Planet Fitness'>PLNT</a>) in <a href=\"https://seekingalpha.com/pr/16911873-planet-fitness-inc-announces-second-quarter-2017-results\" target=\"_blank\">Q2</a>.</li> <li>Franchise segment revenue jumped 28.2% during the quarter to $37.8M.</li> <li>Corporate-owned stores segment revenue rose 7.2% to $28.3M.</li> <li>Equipment segment revenue increased 15.8% to $41.2M.</li><li>Looking ahead, Planet Fitness sees FY17 revenue of $409M to $415M vs. $412.5M consensus and comparable sales growth of 8% to 9%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287710-planet-fitness-beats-0_03-beats-revenue\" target=\"_blank\">Planet Fitness beats by $0.03, beats on revenue</a> (Aug. 9)</li> <li>PLNT <font color='green'>+3.60%</font> AH to $23.87.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287733\" data-linked=\"Strong sales growth for Planet Fitness\" data-tweet=\"$PLNT - Strong sales growth for Planet Fitness https://seekingalpha.com/news/3287733-strong-sales-growth-for-planet-fitness?source=tweet\" data-url=\"https://seekingalpha.com/news/3287733-strong-sales-growth-for-planet-fitness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287732\" data-ts=\"1502309715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRS\" target=\"_blank\">ACRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287732-aclaris-readies-75m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aclaris readies $75M stock offering</a></h4><ul><li>Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a>) <a href=\"https://seekingalpha.com/pr/16911844-aclaris-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of $75M of common stock. Price, volume and terms have yet to be announced.</li><li>Today's close was $26.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287732\" data-linked=\"Aclaris readies $75M stock offering\" data-tweet=\"$ACRS - Aclaris readies $75M stock offering https://seekingalpha.com/news/3287732-aclaris-readies-75m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3287732-aclaris-readies-75m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287723\" data-ts=\"1502309580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287723-alnylam-q2-loss-widens-apollo-data-nears\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam Q2 loss widens; APOLLO data nears</a></h4><ul><li>Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) <a href=\"https://seekingalpha.com/pr/16911831-alnylam-pharmaceuticals-reports-second-quarter-2017-financial-results-highlights-recent\" target=\"_blank\">Q2 results</a> ($M): Collaboration revenue: 15.9 (+82.8%).</li><li>Net Loss: (118.4) (-31.4%); Loss/Share: (1.34) (-27.6).</li><li>Top-line data from Phase 3 APOLLO study of RNAi candidate patisiran in hATTR amyloidosis expected in coming weeks.</li><li>Expects to end the year with more than $1B in quick assets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287723\" data-linked=\"Alnylam Q2 loss widens; APOLLO data nears\" data-tweet=\"$ALNY - Alnylam Q2 loss widens; APOLLO data nears https://seekingalpha.com/news/3287723-alnylam-q2-loss-widens-apollo-data-nears?source=tweet\" data-url=\"https://seekingalpha.com/news/3287723-alnylam-q2-loss-widens-apollo-data-nears\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287720\" data-ts=\"1502309544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDSN\" target=\"_blank\">HDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287720-hudson-tech-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson Tech beats by $0.04, beats on revenue</a></h4><ul><li>Hudson Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a>): Q2 EPS of $0.20 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $52.23M (+51.0% Y/Y) <font color='green'>beats by $5.89M</font>.</li><li>Shares <font color='green'>+13.69%</font>.</li><li><a href='https://seekingalpha.com/pr/16911928-hudson-technologies-reports-record-revenues-52_2-million-second-quarter-2017-diluted-eps-0_20'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3287720\" data-linked=\"Hudson Tech beats by $0.04, beats on revenue\" data-tweet=\"$HDSN - Hudson Tech beats by $0.04, beats on revenue https://seekingalpha.com/news/3287720-hudson-tech-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3287720-hudson-tech-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287708\" data-ts=\"1502308754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPOR\" target=\"_blank\">GPOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287708-gulfport-energyplus-5-after-easy-q2-earnings-revenue-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulfport Energy +5% after easy Q2 earnings, revenue beats</a></h4><ul>     <li>Gulfport Energy (<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color='green'>+5.5%</font>) finishes with strong gains after reporting better than expected <a href=\"https://seekingalpha.com/news/3286965-gulfport-energy-beats-0_06-beats-revenue\" target=\"_blank\">Q2 earnings</a> and revenue.</li>     <li>GPOR says total production during Q2 averaged slightly more than 1B cfe/day (88% from natural gas), a 22% increase over Q1 and 56% higher than the year-ago quarter.</li>     <li>For the six-month period ended June 30, GPOR says its drilling and completion capital spending totaled $536M, midstream capex was $23M and leasehold capex came in at $55M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287708\" data-linked=\"Gulfport Energy +5% after easy Q2 earnings, revenue beats\" data-tweet=\"$GPOR - Gulfport Energy +5% after easy Q2 earnings, revenue beats https://seekingalpha.com/news/3287708-gulfport-energyplus-5-after-easy-q2-earnings-revenue-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3287708-gulfport-energyplus-5-after-easy-q2-earnings-revenue-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287685\" data-ts=\"1502308430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAXR\" target=\"_blank\">MAXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287685-hughes-chooses-space-systems-loral-to-build-next-gen-satellite\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hughes chooses Space Systems Loral to build next-gen satellite</a></h4><ul>   <li>Hughes (<a href=\"http://seekingalpha.com/symbol/SATS\" target=\"_blank\">SATS</a> <font color='red'>-5.2%</font>) has <a href=\"https://seekingalpha.com/pr/16911640-hughes-selects-space-systems-loral-build-next-generation-ultra-high-density-satellite\" target=\"_blank\">gone with Space Systems Loral</a> (MDDWF) to build a next-generation satellite.</li>    <li>The companies will work on EchoStar XXIV, a JUPITER 3 ultra high-density satellite, aimed at key markets across the Americas.</li>    <li>The technology is expected to offer a heavy upgrade in performance, doubling Hughes' Ka-band capacity and offering speeds of 100 Mbps.</li>    <li>The satellite is currently set for launch in early 2021.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287685\" data-linked=\"Hughes chooses Space Systems Loral to build next-gen satellite\" data-tweet=\"$MAXR $MAXR $SATS - Hughes chooses Space Systems Loral to build next-gen satellite https://seekingalpha.com/news/3287685-hughes-chooses-space-systems-loral-to-build-next-gen-satellite?source=tweet\" data-url=\"https://seekingalpha.com/news/3287685-hughes-chooses-space-systems-loral-to-build-next-gen-satellite\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287681\" data-ts=\"1502307899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLR\" target=\"_blank\">CLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287681-continental-resources-to-take-on-absolutely-no-new-debt-ceo-hamm-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Continental Resources to take on &quot;absolutely no new debt,&quot; CEO Hamm says</a></h4><ul>     <li>Continental Resources (<a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a> <font color='green'>+6.2%</font>) is among today's biggest gainers among oil and gas producers after <a href=\"https://seekingalpha.com/news/3287252-continental-resources-cuts-full-year-capex-hiking-production-guidance\" target=\"_blank\">Q2 results</a> included a capex cut paired with a production guidance increase for the full year.</li>     <li>CEO&nbsp;Harold Hamm said in today's earnings conference call that CLR will take \"<a href=\"http://www.reuters.com/article/us-contl-resources-debt-idUSKBN1AP274\" target=\"_blank\">absolutely do new debt</a>\" and forgo some growth opportunities as it curtails spending and funds future wells only from cash flow.</li>     <li>Hamm also said he sees WTI crude oil regaining price \"dominance\" over Brent after trading at a slight discount to the global benchmark for years; if that dynamic were to flip, it would be a boon for CLR and its peers.</li>     <li>\"In the meantime, we believe that the long-term oil supply cannot be sustained at $50 WTI. There simply won't be adequate capital investment long term at this price to adequately supply market demand growth,\" according to Hamm.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287681\" data-linked=\"Continental Resources to take on &quot;absolutely no new debt,&quot; CEO Hamm says\" data-tweet=\"$CLR - Continental Resources to take on &quot;absolutely no new debt,&quot; CEO Hamm says https://seekingalpha.com/news/3287681-continental-resources-to-take-on-absolutely-no-new-debt-ceo-hamm-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3287681-continental-resources-to-take-on-absolutely-no-new-debt-ceo-hamm-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287673\" data-ts=\"1502306569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287673-kandi-technologies-breaks-lower-after-weak-revenue-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi Technologies breaks lower after weak revenue print</a></h4><ul> <li>Kandi Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) is <font color='red'>down 6.25%</font> after Q2 revenue comes in at half of last year's level.</li><li>Volume and pricing was down during the quarter.</li> <li>Kandi management says they are actively seeking strategic investors.</li> <li>Shares have slumped to their lowest level since April.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287673\" data-linked=\"Kandi Technologies breaks lower after weak revenue print\" data-tweet=\"$KNDI - Kandi Technologies breaks lower after weak revenue print https://seekingalpha.com/news/3287673-kandi-technologies-breaks-lower-after-weak-revenue-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3287673-kandi-technologies-breaks-lower-after-weak-revenue-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287672\" data-ts=\"1502306374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287672-charter-closes-sale-of-1_5b-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charter closes sale of $1.5B in debt</a></h4><ul>   <li>Charter Communications (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='green'>+2.7%</font>) closed on an upsized offering of <a href=\"https://seekingalpha.com/pr/16910734-charter-closes-1_5-billion-senior-unsecured-notes\" target=\"_blank\">$1.5B in unsecured debt</a>.</li>    <li>The company sold that amount in senior unsecured notes due 2028 at 5%.</li>    <li>It had said that it would use net proceeds for general purposes, including buybacks of stock or of common units of its LLC, Charter Communications Holdings.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287561-charter-plus-3_9-percent-report-altice-weighing-bid-company\" target=\"_blank\">Charter +3.9% on report Altice is weighing bid for company</a> (Aug. 09 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287672\" data-linked=\"Charter closes sale of $1.5B in debt\" data-tweet=\"$CHTR - Charter closes sale of $1.5B in debt https://seekingalpha.com/news/3287672-charter-closes-sale-of-1_5b-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3287672-charter-closes-sale-of-1_5b-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287669\" data-ts=\"1502305204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287669-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/SSNI' title='Silver Spring Networks'>SSNI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TCX' title='Tucows Inc'>TCX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CYRN' title='CYREN Ltd.'>CYRN</a> <font color='green'>+11%</font>. FH <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CALX' title='Calix, Inc.'>CALX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CLRO' title='ClearOne, Inc.'>CLRO</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/MATR' title='Mattersight Corporation'>MATR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VSAT' title='Viasat, Inc.'>VSAT</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287669\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$GRVY $SSNI $TCX - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3287669-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3287669-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287667\" data-ts=\"1502304714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FQVLF\" target=\"_blank\">FQVLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287667-first-quantum-to-suspend-australias-ravensthorpe-nickel-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Quantum to suspend Australia&#39;s Ravensthorpe nickel mine</a></h4><ul>     <li>First Quantum Minerals (<a href='https://seekingalpha.com/symbol/FQVLF' title='First Quantum Minerals Ltd.'>OTCPK:FQVLF</a> <font color='red'>-5.1%</font>) says it will <a href=\"https://www.bloomberg.com/news/articles/2017-08-09/first-quantum-to-suspend-operations-at-ravensthorpe-nickel-op\" target=\"_blank\">suspend operations</a> at its Ravensthorpe nickel operation in&nbsp;Western Australia, citing persistently low prices for the metal.</li>     <li>First Quantum says it will place Ravensthorpe on care and maintenance next month at an estimated cost of $10M plus $5M/year, adding that a restart would cost ~$10M.</li>     <li>The Canadian company bought the shuttered mine from BHP in 2009 for $340M and restarted operations in 2011, when nickel prices averaged ~$22.8K/metric ton; while most industrial metals have rallied more than 30% in the past year, nickel is little changed with prices averaging just $9.8K in 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287667\" data-linked=\"First Quantum to suspend Australia&#39;s Ravensthorpe nickel mine\" data-tweet=\"$FQVLF - First Quantum to suspend Australia&#39;s Ravensthorpe nickel mine https://seekingalpha.com/news/3287667-first-quantum-to-suspend-australias-ravensthorpe-nickel-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3287667-first-quantum-to-suspend-australias-ravensthorpe-nickel-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287666\" data-ts=\"1502304571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287666-disneyminus-4_9-analysts-praise-streaming-move-despite-short-term-pain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney -4.9%; analysts praise streaming move despite short-term pain</a></h4><ul>   <li>Walt Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) is <font color='red'>4.9% lower</font> today after yesterday's <a href=\"https://seekingalpha.com/news/3287045-tv-drag-parks-bright-spot-disney-profits-revenues-fall\" target=\"_blank\">earnings disappointment</a>, dragging a Dow that's still a bit underwater today (<font color='red'>-0.4%</font>) though most components are making fractional moves.</li>    <li>If investors aren't impressed with Disney's situation ahead, several analysts are. Goldman Sachs reiterated a Buy rating and $133 price target, implying 31% upside from today's lower price. There's a lot of unanswered questions around plans for <a href=\"https://seekingalpha.com/news/3286989-disney-taking-bamtech-launch-espn-disney-streaming-services\" target=\"_blank\">new ESPN and Disney over-the-top services</a>, but it's the right long-term move and should improve bargaining power for affiliate distribution and live sports rights, says Drew Borst.</li>    <li>RBC's Steven Cahall sees a \"bumpier road near-term\" as Disney gives up its \"bird in the hand\" by pulling content from Netflix, but that investors will ultimately reward long-term thinking as Disney sets retail pricing for its content rather than wholesale. He has a $130 price target.</li>    <li>UBS lowered its price target to $126 from $130, noting that shareholder profits could be <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/08/9902451/long-live-the-king-disney-takes-streaming-into-its-own-h\" target=\"_blank\">hit in the short term</a> from loss of sales to subscription VOD services and decreased ad revenues.</li>    <li>One notable bear is sticking to his guns: Pivotal's Brian Wieser reiterated a Sell rating and agreed that while going direct to consumer is the right strategic move, the price Disney paid for BAMTech implies a \"frothy\" valuation of $4B. (h/t: Bloomberg)</li>    <li>He has an $85 price target, implying 16.5% downside ahead.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287666\" data-linked=\"Disney -4.9%; analysts praise streaming move despite short-term pain\" data-tweet=\"$DIS - Disney -4.9%; analysts praise streaming move despite short-term pain https://seekingalpha.com/news/3287666-disneyminus-4_9-analysts-praise-streaming-move-despite-short-term-pain?source=tweet\" data-url=\"https://seekingalpha.com/news/3287666-disneyminus-4_9-analysts-praise-streaming-move-despite-short-term-pain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287664\" data-ts=\"1502303571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSLR\" target=\"_blank\">VSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287664-vivint-solarminus-2_5-q2-installations-decline-deutsche-bank-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivint Solar -2.5% as Q2 installations decline, Deutsche Bank downgrades</a></h4><ul>     <li>Vivint Solar (<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='red'>-2.5%</font>) is lower after reporting better than expected <a href=\"https://seekingalpha.com/news/3286973-vivint-solar-beats-0_07-beats-revenue\" target=\"_blank\">Q2 earnings</a> but a 23% Y/Y drop in installations to 47 MW and reduce full-year guidance to 185-200 MW.</li>     <li>In response, Deutsche Bank <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/08/9901662/sun-sets-on-near-term-catalysts-for-vivint-solar-deutsch\" target=\"_blank\">downgrades</a> VSLR to Hold from Buy with a $5.50 price target, trimmed from $6, as it sees limited near-term catalysts with shares also reflecting some of the company's near-term financial turnaround.</li><li>The firm points out that VSLR's projections pale in comparison to rival Sunrun (<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='red'>-3.5%</font>), which sees 15% growth this year in installations vs. VSLR&rsquo;s anticipated 13% decline.</li><li>But Deutsche Bank also believes some of VSLR's recent strategic sales initiatives that negatively  impacted volumes and market share likely will drive overall profitability improvement in the long term.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287664\" data-linked=\"Vivint Solar -2.5% as Q2 installations decline, Deutsche Bank downgrades\" data-tweet=\"$VSLR $VSLR $RUN - Vivint Solar -2.5% as Q2 installations decline, Deutsche Bank downgrades https://seekingalpha.com/news/3287664-vivint-solarminus-2_5-q2-installations-decline-deutsche-bank-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3287664-vivint-solarminus-2_5-q2-installations-decline-deutsche-bank-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287663\" data-ts=\"1502302959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287663-blue-apron-rallies-earnings-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron rallies into earnings day</a></h4><ul><li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is&nbsp;<font color='green'>up 5.68%</font>&nbsp;a day ahead of the company's first earnings report as a publicly-traded entity.</li><li>Analysts expect Blue Apron to report Q2 revenue of $236M and EPS of -$0.30. Full-year guidance for revenue of $1.01B and EPS of -$0.99 is also anticipated.</li><li>What to watch: Blue Apron's conference call could give some clarity on how management is handling churn and what it expects from the Amazon-Whole Foods combination.</li><li>Seeking Alpha contributor Kevin Mak has a more detailed <a href=\"https://seekingalpha.com/article/4093265-blue-apron-q2-earnings-preview-analysis\" target=\"_blank\">earnings preview</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287663\" data-linked=\"Blue Apron rallies into earnings day\" data-tweet=\"$APRN - Blue Apron rallies into earnings day https://seekingalpha.com/news/3287663-blue-apron-rallies-earnings-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3287663-blue-apron-rallies-earnings-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287660\" data-ts=\"1502302467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYNE\" target=\"_blank\">ZYNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287660-zynerba-rebounds-32-dead-cat-bounce-reversal-of-fortune\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynerba rebounds 32%, dead cat bounce or reversal of fortune?</a></h4><ul><li>Zynerba Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+31.6%</font>) jumps on a 4x surge in volume, a welcome move for battered longs and timely bargain hunters. Shares had lost 60% of their value after the company announced ZYN002's mid-stage flop in epilepsy on Monday.</li><li>Intrepid investors, like <a href=\"https://seekingalpha.com/article/4096421-zynerba-pharmaceuticals-buy-ahead-osteoarthritis-data\" target=\"_blank\">SA Contributor Bhavneesh Sharma</a>, are staying the course, saying ZYN002 may be a winner in osteoarthritis since its topical formulation would work like a lidocaine or fentanyl patch. Top-line data from a Phase 2 clinical trial are expected in the next few weeks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286181-zynerbas-zyn002-flunks-mid-stage-epilepsy-study-shares-48-percent-premarket\" target=\"_blank\">Zynerba's ZYN002 flunks mid-stage epilepsy study; shares down 48% premarket</a> (Aug. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287660\" data-linked=\"Zynerba rebounds 32%, dead cat bounce or reversal of fortune?\" data-tweet=\"$ZYNE - Zynerba rebounds 32%, dead cat bounce or reversal of fortune? https://seekingalpha.com/news/3287660-zynerba-rebounds-32-dead-cat-bounce-reversal-of-fortune?source=tweet\" data-url=\"https://seekingalpha.com/news/3287660-zynerba-rebounds-32-dead-cat-bounce-reversal-of-fortune\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287658\" data-ts=\"1502301673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287658-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MPO' title='Midstates Petroleum'>MPO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TTI' title='Tetra Technologies Inc.'>TTI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287658\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$XEC $SNEC $CLR - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3287658-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3287658-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287656\" data-ts=\"1502301482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDOT\" target=\"_blank\">GDOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287656-multi-year-high-for-green-dot-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Multi-year high for Green Dot after earnings</a></h4><ul>     <li>Shares of Green Dot (<a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+15.7%</font>) race to their highest level since 2011 after the company bests Q2 earnings estimates.</li>     <li>Sell-side analyts are also stoking interest in Green Dot. Lake Street upgrades the payments stock to a Buy rating and lifts its price target to $44, while a Compass Point note tips that there is a \"medium-high likelihood\" GDOT could be acquired in the next 12-18 months.</li><li>Sources: Bloomberg and CNBC</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287003-green-dot-beats-0_15-beats-revenue\" target=\"_blank\">Green Dot beats by $0.15, beats on revenue</a> (Aug. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287656\" data-linked=\"Multi-year high for Green Dot after earnings\" data-tweet=\"$GDOT - Multi-year high for Green Dot after earnings https://seekingalpha.com/news/3287656-multi-year-high-for-green-dot-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3287656-multi-year-high-for-green-dot-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287653\" data-ts=\"1502301194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287653-disney-miss-streaming-move-weighs-on-cord-affected-media-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney miss, streaming move weighs on cord-affected media shares</a></h4><ul>     <li>Media stocks are lower today as a <a href=\"https://seekingalpha.com/news/3287045-tv-drag-parks-bright-spot-disney-profits-revenues-fall\" target=\"_blank\">miss by Walt Disney</a> (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-4.6%</font>) and a <a href=\"https://seekingalpha.com/news/3286989-disney-taking-bamtech-launch-espn-disney-streaming-services\" target=\"_blank\">sea change to its streaming distribution</a> ripples out sectorwide.</li>     <li>Disney's move to take majority control of BAMTech, and use that as a springboard to launch over-the-top services around ESPN and the parent Disney brand, are stoking talk about the speed with which cord-cutting is affecting numerous media stakeholders.</li>     <li>With a growing number of services built around single channels, and consolidation speeding up, analysts are looking to which channels may be left without OTT dance partners in the unbundled future.</li>     <li>Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='red'>-1.2%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-2.9%</font>), home to channels including MTV, BET, Comedy Central and Nickelodeon, is lower today. Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2.1%</font>) is too, as is CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.4%</font>), though NBC owner Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.6%</font>) is bucking the tide.</li>     <li>Discovery (NASDAQ:<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>) -- set to combine with Scripps Networks Interactive (NYSE:<a href='https://seekingalpha.com/symbol/SNI' title='Scripps Networks Interactive, Inc.'>SNI</a>) -- is <font color='red'>3.7% lower</font>, while SNI is <font color='red'>0.5% lower</font>.</li>     <li>AMC Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/AMCX' title='AMC Networks Inc.'>AMCX</a>), one of the \"odd network out\" risks, is <font color='red'>off 0.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287653\" data-linked=\"Disney miss, streaming move weighs on cord-affected media shares\" data-tweet=\"$VIA $VIA $VIAB - Disney miss, streaming move weighs on cord-affected media shares https://seekingalpha.com/news/3287653-disney-miss-streaming-move-weighs-on-cord-affected-media-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3287653-disney-miss-streaming-move-weighs-on-cord-affected-media-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287648\" data-ts=\"1502300171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EL\" target=\"_blank\">EL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287648-oppenheimer-sees-estee-lauder-rally-extending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer sees Estee Lauder rally extending</a></h4><ul>     <li>Estee Lauder (<a href='https://seekingalpha.com/symbol/EL' title='Estee Lauder Companies, Inc. &#40;The&#41;'>EL</a> <font color='green'>+2.3%</font>) pokes out a tidy gain after Oppenheimer pitches the <a href=\"https://www.streetinsider.com/Analyst+Comments/Est%C3%83%C2%A9e+Lauder+%28EL%29%3A+Reiterating+Top+Pick+-+Oppenheimer/13185410.html\" target=\"_blank\">upside case</a>.</li>     <li>The firm says the cosmetics seller's earnings can improve in 2018 and 2019 as momentum accelerates in key international markets and the impact from recent acquisitions kicks in. Partnerships with Ulta nd Sephora are also seen as a positive.</li>     <li>\"We no longer view EL shares as cheap, but believe investors are likely to assign a higher multiple to shares given the current backdrop,\" writes analyst Rupesh Parikh.</li><li>Oppy has an Outperform rating and $110 price target on EL.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287648\" data-linked=\"Oppenheimer sees Estee Lauder rally extending\" data-tweet=\"$EL - Oppenheimer sees Estee Lauder rally extending https://seekingalpha.com/news/3287648-oppenheimer-sees-estee-lauder-rally-extending?source=tweet\" data-url=\"https://seekingalpha.com/news/3287648-oppenheimer-sees-estee-lauder-rally-extending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287644\" data-ts=\"1502299028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287644-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/LTS' title='Ladenburg Thalmann Financial Services Inc.'>LTS</a> <font color='green'>+11%</font>.<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/HRTG' title='Heritage Insurance Holdings, Inc.'>HRTG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IMH' title='Impac Mortgage Holdings, Inc.'>IMH</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FNGN' title='Financial Engines, Inc.'>FNGN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-24%</font>. RAS <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287644\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$GDOT $LTS $GTS - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3287644-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3287644-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287639\" data-ts=\"1502297360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XCO\" target=\"_blank\">XCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287639-exco-resourcesminus-15-on-rising-liquidity-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EXCO Resources -15% on rising liquidity concerns</a></h4><ul>     <li>EXCO&nbsp;Resources (<a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='red'>-15.6%</font>) plunges following <a href=\"https://seekingalpha.com/news/3287002-exco-resources-beats-0_04\" target=\"_blank\">Q2 results</a> that included doubts about the company's ability to comply with debt covenants.</li>     <li>Along with its Q2 report after yesterday's close, XCO updated the progress on its capital structure: \"Our liquidity and compliance with debt covenants may be impacted by the outcome of certain litigation and the potential closing of the divestiture of our south Texas properties.\"</li><li>XCO also <a href=\"https://www.sec.gov/Archives/edgar/data/316300/000031630017000027/q22017-xco10q.htm\" target=\"_blank\">disclosed</a> that current litigation brought by Enterprise Products and Acadian Gas  Pipeline claiming the company violated sales and transportation contracts has the potential to hurt its ability to meet its debt obligations.</li><li>On its earnings conference call, XCO said the deadline for the sale of the south Texas properties has been extended to August 15 but further postponements are possible.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287639\" data-linked=\"EXCO Resources -15% on rising liquidity concerns\" data-tweet=\"$XCO - EXCO Resources -15% on rising liquidity concerns https://seekingalpha.com/news/3287639-exco-resourcesminus-15-on-rising-liquidity-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3287639-exco-resourcesminus-15-on-rising-liquidity-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287635\" data-ts=\"1502297311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287635-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STS' title='Supreme Industries, Inc'>STS</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SSNI' title='Silver Spring Networks'>SSNI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EVRI' title='Everi Holdings Inc.'>EVRI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/WAIR' title='Wesco Aircraft Holdings'>WAIR</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/ODP' title='Office Depot Inc.'>ODP</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/VEC' title='Vectrus'>VEC</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CALX' title='Calix, Inc.'>CALX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='red'>-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287635\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$STS $CBLI $NTRA - Midday Gainers / Losers https://seekingalpha.com/news/3287635-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3287635-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287632\" data-ts=\"1502296407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287632-ringcentral-hires-advisor-for-takeover-offers-sharesplus-8_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral hires advisor for takeover offers; shares +8.8%</a></h4><ul>     <li>              <a href=\"https://www.bloomberg.com/news/articles/2017-08-09/ringcentral-is-said-to-work-with-adviser-after-takeover-interest\" target=\"_blank\">Bloomberg</a> reports that RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) has hired an advisor to handle takeover interest. </li>     <li> Sources say the cloud software company could attract interest from private equity firms or other software providers. </li>     <li> Details weren&rsquo;t disclosed and RingCentral hasn&rsquo;t committed to a sale. </li>     <li> RingCentral shares are&nbsp;<font color='green'>up 8.77%</font>. &nbsp; </li> </ul><div class=\"tiny-share-widget\" data-id=\"3287632\" data-linked=\"RingCentral hires advisor for takeover offers; shares +8.8%\" data-tweet=\"$RNG - RingCentral hires advisor for takeover offers; shares +8.8% https://seekingalpha.com/news/3287632-ringcentral-hires-advisor-for-takeover-offers-sharesplus-8_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3287632-ringcentral-hires-advisor-for-takeover-offers-sharesplus-8_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287626\" data-ts=\"1502295775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTN\" target=\"_blank\">RTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287626-big-three-defense-stocks-hit-all-time-highs-north-korea-rhetoric-rises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big three defense stocks hit all-time highs as North Korea rhetoric rises</a></h4><ul>     <li>Raytheon (<a href='https://seekingalpha.com/symbol/RTN' title='Raytheon Company'>RTN</a> <font color='green'>+2.3%</font>), Lockheed Martin (<a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color='green'>+1.6%</font>) and Northrop Grumman (<a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color='green'>+1.1%</font>) all <a href=\"https://www.cnbc.com/2017/08/09/major-defense-stocks-surge-to-all-time-highs-after-trumps-tough-rhetoric-against-north-korea.html\" target=\"_blank\">rise to new all-time highs</a> a day after Pres. Trump's \"fire and fury\" threat against North Korea, even as the rest of the market is lower on concerns about increased geopolitical tensions.</li>     <li>RTN and LMT helped build the THAAD missile defense system in the Asian region, and RTN manufactures Tomahawk cruise missiles; the three stocks <a href=\"https://blogs.wsj.com/moneybeat/2017/08/09/defense-stocks-up-as-north-korea-rhetoric-intensifies/\" target=\"_blank\">tend to gain</a> when there is increased chatter about war.</li>     <li><a href=\"https://seekingalpha.com/news/3286791-morgan-stanley-weighs-defense-sector\" target=\"_blank\">Yesterday</a>, Morgan Stanley launched coverage of the defense sector, saying the group has room to run despite strong YTD gains amid the high threat environment in the world and \"clearly expanding\" defense budgets over the next few years, \"with upside potential via a more functional political backdrop.\"</li>     <li>Stanley started LMT and RTN with Overweight ratings but initiated General Dynamics (<a href='https://seekingalpha.com/symbol/GD' title='General Dynamics Corporation'>GD</a> <font color='green'>+1.4%</font>) at <a href=\"http://www.barrons.com/articles/the-two-most-attractive-defense-stocks-are-1502204757\" target=\"_blank\">Underweight</a>, as the firm thinks Gulfstream \"may have difficulty sustaining margins at ~2x vs. peers while threats from Bombardier, Dassault and Textron arrive into decade-end.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3287626\" data-linked=\"Big three defense stocks hit all-time highs as North Korea rhetoric rises\" data-tweet=\"$RTN $RTN $LMT - Big three defense stocks hit all-time highs as North Korea rhetoric rises https://seekingalpha.com/news/3287626-big-three-defense-stocks-hit-all-time-highs-north-korea-rhetoric-rises?source=tweet\" data-url=\"https://seekingalpha.com/news/3287626-big-three-defense-stocks-hit-all-time-highs-north-korea-rhetoric-rises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287624\" data-ts=\"1502295256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287624-omeros-q2-beat-propels-shares-up-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros Q2 beat propels shares, up 13%</a></h4><ul><li>Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+12.5%</font>) bucks the market's selloff, albeit on light volume. After the close yesterday, the company released <a href=\"https://seekingalpha.com/pr/16910345-omeros-corporation-reports-second-quarter-2017-financial-results\" target=\"_blank\">Q2 results</a> that beat consensus.</li><li>Omidria sales were up 71% to $17.2M, units shipped rose 113%.</li><li>Loss per share was about the same: ($0.33) vs. ($0.32).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286969-omeros-beats-0_15-beats-revenue\" target=\"_blank\">Omeros beats by $0.15, beats on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287624\" data-linked=\"Omeros Q2 beat propels shares, up 13%\" data-tweet=\"$OMER - Omeros Q2 beat propels shares, up 13% https://seekingalpha.com/news/3287624-omeros-q2-beat-propels-shares-up-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3287624-omeros-q2-beat-propels-shares-up-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287621\" data-ts=\"1502294641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SATS\" target=\"_blank\">SATS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287621-echostarminus-4_2-higher-costs-lead-to-profit-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EchoStar -4.2% as higher costs lead to profit miss</a></h4><ul>   <li>EchoStar (NASDAQ:<a href='https://seekingalpha.com/symbol/SATS' title='EchoStar Corporation'>SATS</a>) is <font color='red'>4.2% lower</font> after profits missed in its <a href=\"https://seekingalpha.com/news/3287303-echostar-misses-0_10-beats-revenue\" target=\"_blank\">Q2 earnings</a>, as higher costs took out a 5% revenue gain.</li>    <li>The company took on $22.3M more in interest expense from 2016 bonds, lost $13.1M in capitalized interest tied to 2017 satellites and saw depreciation expense on those satellites rise by $24M.</li>    <li>EBITDA of $184.9M beat an expected $176.3M.</li>    <li>The company reported Hughes broadband subscribers came to 1.085M as of June 30.</li>    <li>Revenue by segment: Hughes, $362.8M (up 6.9%); EchoStar Satellite Services, $98.4M (down 3%); corporate and other, $3.95M (up 111%).</li>    <li>EBITDA by segment: Hughes, $110M (down 6.5%); EchoStar Satellite Services, $80.5M (down 4.5%); corporate and other, -$5.6M.</li>    <li>Cash, equivalents and marketable securities came to $3.27B as of June 30.</li>    <li><a href=\"https://seekingalpha.com/pr/16910820-echostar-announces-financial-results-three-six-months-ending-june-30-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287621\" data-linked=\"EchoStar -4.2% as higher costs lead to profit miss\" data-tweet=\"$SATS - EchoStar -4.2% as higher costs lead to profit miss https://seekingalpha.com/news/3287621-echostarminus-4_2-higher-costs-lead-to-profit-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3287621-echostarminus-4_2-higher-costs-lead-to-profit-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287619\" data-ts=\"1502294477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287619-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STS' title='Supreme Industries, Inc'>STS</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BUFF' title='Blue Buffalo'>BUFF</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/COKE' title='Coca-Cola Consolidated, Inc.'>COKE</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TWNK' title='Hostess Brands, Inc.'>TWNK</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287619\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$STS $EFOI $FTFT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3287619-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3287619-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287616\" data-ts=\"1502294306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287616-myriad-fq4-beat-stokes-buying-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad FQ4 beat stokes buying, shares up 5%</a></h4><ul><li>Myriad Genetics (<a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color='green'>+4.5%</font>) is up on 20% higher volume after the company posted fiscal Q4 results that beat consensus.</li><li>EPS was $0.19 (-40.6%) on revenues of $200.5M (+7.5%).</li><li>86% of revenue is now under long-term contracts.</li><li>GeneSight sales increased 34% in fiscal 2017.</li><li><strong>Fiscal 2018 Guidance</strong>: &nbsp;Revenues: $750M - 770M, EPS: $0.37 - 0.42; Non-GAAP EPS: $1.00 - 1.05.</li><li><strong>Fiscal Q1 Guidance</strong>: Revenues: $181M - 183M; EPS: $0.05 - 0.07; Non-GAAP EPS: $0.19 - 0.21.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287007-myriad-genetics-beats-0_04-beats-revenue\" target=\"_blank\">Myriad Genetics beats by $0.04, beats on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287616\" data-linked=\"Myriad FQ4 beat stokes buying, shares up 5%\" data-tweet=\"$MYGN - Myriad FQ4 beat stokes buying, shares up 5% https://seekingalpha.com/news/3287616-myriad-fq4-beat-stokes-buying-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3287616-myriad-fq4-beat-stokes-buying-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287622\" data-ts=\"1502294303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287622-transocean-upgraded-to-neutral-from-sell-goldman-shares-down-anyway\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean upgraded to Neutral from Sell at Goldman; shares down anyway</a></h4><ul>     <li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-3.7%</font>) is sharply lower despite enjoying an <a href=\"https://www.thestreet.com/story/14263918/1/transocean-stock-sinks-despite-goldman-upgrade.html\" target=\"_blank\">upgrade</a> to Neutral from Sell at Goldman Sachs, although with a reduced $9.75 price target vs. $11.50 previously.</li>     <li>Goldman says RIG has enhanced its balance sheet over the past several months, and the firm now sees leveraged metrics to be relatively better than the peer group in the 2019-20 time frame.</li>     <li>Goldman also notes that RIG will now operate as a pure play floater company, a segment that appears&nbsp;to have bottomed out.</li><li>Offshore drillers are lower across the board: <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-8.3</font>%, <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='red'>-7.9%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='red'>-5.1%</font>, <a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='red'>-4.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287622\" data-linked=\"Transocean upgraded to Neutral from Sell at Goldman; shares down anyway\" data-tweet=\"$RIG $RIG $VAL - Transocean upgraded to Neutral from Sell at Goldman; shares down anyway https://seekingalpha.com/news/3287622-transocean-upgraded-to-neutral-from-sell-goldman-shares-down-anyway?source=tweet\" data-url=\"https://seekingalpha.com/news/3287622-transocean-upgraded-to-neutral-from-sell-goldman-shares-down-anyway\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287614\" data-ts=\"1502293702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ODP\" target=\"_blank\">ODP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287614-office-depotminus-23-sales-pressure-mounts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Office Depot -23% as sales pressure mounts</a></h4><ul> <li>Office Depot (NYSE:<a href='https://seekingalpha.com/symbol/ODP' title='Office Depot Inc.'>ODP</a>) falls sharply after reporting a 6% drop in comparable sales for Q2. Traffic fell and the average order size at ODP stores fell back.</li> <li>Management said that despite the \"competitive pressures\" in the sector YTD operating income is ahead of last year's pace.</li> <li>The company closed 31 stores during the quarter as it focused on profitability.</li> <li>Shares of Office Depot are <font color='red'>down 23%</font> on heavy volume to effectively erase what had been a gentle 6-month uptrend.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287340-office-depot-misses-0_02-misses-revenue\" target=\"_blank\">Office Depot misses by $0.02, misses on revenue</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287614\" data-linked=\"Office Depot -23% as sales pressure mounts\" data-tweet=\"$ODP - Office Depot -23% as sales pressure mounts https://seekingalpha.com/news/3287614-office-depotminus-23-sales-pressure-mounts?source=tweet\" data-url=\"https://seekingalpha.com/news/3287614-office-depotminus-23-sales-pressure-mounts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287610\" data-ts=\"1502293167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287610-moleculin-chief-says-recent-aml-drug-approvals-bode-well-for-annamycin-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin chief says recent AML drug approvals bode well for Annamycin; shares ahead 7%</a></h4><ul><li>Nano cap Moleculin Biotech (<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+6.7%</font>) bucks the market's sour mood, albeit on light volume.</li><li>This morning, CEO Walter Kemp <a href=\"https://seekingalpha.com/pr/16911024-moleculin-comments-recent-fda-drug-approvals-acute-myeloid-leukemia\" target=\"_blank\">weighed in</a> on three recent U.S. drug approvals for treating acute myeloid leukemia &#40;AML&#41; that he says bodes well for the ability of chemo candidate Annamycin to fill major areas of first-line AML treatment.</li><li>Mr. Kemp explains that Novartis' Rydapt (midostaurin), OK'd by the FDA in April, is approved to treat only AML patients with a specific genetic mutation (FLT3). Jazz Pharmaceuticals' Vyxeos (cytarabine and daunorubicin), OK'd in the U.S. on August 8, is approved as an option to standard-of-care therapy, but only for newly diagnosed therapy-related AML patients or AML with myelodysplasia-related changes. Celgene's IDHIFA (enasidenib), OK'd on August 1, showed a 19% response rate in treatment-resistant AML patients with the genetic mutation IDH2, a population representing only 13% of AML cases.</li><li>He says that the FDA granted accelerated approval for IDHIFA based on a single Phase 1/2 study and based on response rate instead of overall survival. He intends to pursue a similar regulatory approach for Annamycin.</li><li>Adding, \"While these new drugs make valuable incremental improvements in AML therapy, most AML patients will still fail to respond to (or relapse from) initial therapy. Therefore, our initial clinical development plan will attempt to address the significant unmet need of patients who relapse from, or are refractory to, initial therapy. We also believe that, if Annamycin can demonstrate superior efficacy and safety to the current standard of care, the drug may be able to fill major areas for first-line AML treatment. In the meantime, these transactions serve to remind us of the opportunity for our company if Annamycin shows significant activity in our planned clinical trials.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3279189-moleculin-licenses-leukemia-candidate-md-anderson-shares-ahead-28-percent-premarket\" target=\"_blank\">Moleculin in-licenses leukemia candidate from MD Anderson; shares ahead 28% premarket</a> (July 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287610\" data-linked=\"Moleculin chief says recent AML drug approvals bode well for Annamycin; shares ahead 7%\" data-tweet=\"$MBRX - Moleculin chief says recent AML drug approvals bode well for Annamycin; shares ahead 7% https://seekingalpha.com/news/3287610-moleculin-chief-says-recent-aml-drug-approvals-bode-well-for-annamycin-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3287610-moleculin-chief-says-recent-aml-drug-approvals-bode-well-for-annamycin-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287607\" data-ts=\"1502291779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287607-mbia-climbs-4-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MBIA climbs 4% after Q2 results</a></h4><ul><li>The company last month got the bad news out of the way - a $1.1B charge to income and book value as a result of a valuation allowance on its DTA, and an estimated $250M-$275M is loss and adjustment reserves from Puerto Rico exposure.</li><li>The impact on adjusted book value, however, is less than <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=jccik-b\" target=\"_blank\">what BTIG analyst Mark Palmer </a>had anticipated - it fell $6.06 per share to $26.26 vs. his expectation of a $6.86 decline.</li><li>He reiterates his Buy rating, and boosts the price target to $14 from $13. That's just under&nbsp;<font color='green'>40% upside</font>&nbsp;from the current $10.07.</li><li><a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a>&nbsp;<font color='green'>+4.1%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3287038-mbia-eps-9_78\" target=\"_blank\">MBIA EPS of -$9.78</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287607\" data-linked=\"MBIA climbs 4% after Q2 results\" data-tweet=\"$MBI - MBIA climbs 4% after Q2 results https://seekingalpha.com/news/3287607-mbia-climbs-4-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287607-mbia-climbs-4-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287600\" data-ts=\"1502291151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGRY\" target=\"_blank\">SGRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287600-surgery-partners-down-35-after-ugly-q2-lowered-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Surgery Partners down 35% after ugly Q2, lowered guidance</a></h4><ul><li>Thinly traded Surgery Partners (<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-34.7%</font>) is getting roughed up in early trading on more than a 10x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/16910414-surgery-partners-inc-announces-second-quarter-2017-results\" target=\"_blank\">Q2 results </a>the badly missed consensus.</li><li>Revenues were $288.4M, down 0.5% while EPS turned negative ($0.09) (-325%). The company attributed the soft results to the broad industry trend of slower patient volumes, a shift to less favorable payers and slow improvement of its integrated physician practice acquisition.</li><li><strong>2017 Guidance</strong>:&nbsp;&nbsp;Revenues: $1.18B - 1.20B (+8% from midpoint, down from Q1 guidance of 9 - 11% growth); Non-GAAP EBITDA: $174M - 181M (down 1% from midpoint and down from Q1 guidance of 10 - 15% growth) on a standalone basis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287051-surgery-partners-misses-0_19-misses-revenue\" target=\"_blank\">Surgery Partners misses by $0.19, misses on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287600\" data-linked=\"Surgery Partners down 35% after ugly Q2, lowered guidance\" data-tweet=\"$SGRY - Surgery Partners down 35% after ugly Q2, lowered guidance https://seekingalpha.com/news/3287600-surgery-partners-down-35-after-ugly-q2-lowered-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3287600-surgery-partners-down-35-after-ugly-q2-lowered-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287599\" data-ts=\"1502290881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTD\" target=\"_blank\">FTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287599-ftd-companiesminus-12-off-of-soft-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTD Companies -12% off of soft earnings</a></h4><ul> <li>Shares of FTD Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a>) spin lower after Q2 numbers from the retailer disappoint.</li> <li>A decrease in sales in the consumer segment was only partially offset by gains in the provide commerce and florist segments. Adjusted EBITDA as a percentage of sales plunged 380 bps to 9.5% of revenue.</li> <li>The company says it's on track to complete its strategic review this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287101-ftd-companies-misses-0_08-misses-revenue\" target=\"_blank\">FTD Companies misses by $0.08, misses on revenue</a> (Aug. 8)</li> <li>FTD <font color='red'>-11.99%</font> to $16.67. Shares traded as low as $13.58 earlier in the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287599\" data-linked=\"FTD Companies -12% off of soft earnings\" data-tweet=\"$FTD - FTD Companies -12% off of soft earnings https://seekingalpha.com/news/3287599-ftd-companiesminus-12-off-of-soft-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3287599-ftd-companiesminus-12-off-of-soft-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287582\" data-ts=\"1502290878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287582-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+18%</font>. IPXL <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/TBPH' title='Theravance Biopharma, Inc.'>TBPH</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287582\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NTRA $ACHN $ACAD - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3287582-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3287582-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287592\" data-ts=\"1502290220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287592-analysts-unflustered-over-loss-of-disney-content-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts unflustered over loss of Disney content at Netflix</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is <font color='red'>down 2.57%</font> as investors digest the impact of Disney pulling its content from the streaming service. For the most past, analysts are hedging that Netflix is well-prepared for life without Disney movies. A few key sell-side quotes are posted below.</li> <li>SunTrust Robinson Humphrey: \"We expect this outcome does not have a meaningful impact on NFLX's existing strategy, given the platform's content slate is already aggressively shifting to owned original content. As an example, the co's first ever acquisition of Millarworld (announced yesterday), a comic book publishing house, further exemplifies the importance of owned IP.\"</li> <li>Jefferies: \"We expect NFLX will increasingly allocate investment into kids programming to limit the impact to sub growth / churn. Over the past week, DIS, CBS &amp; FOX have announced new DTC offerings.\"</li> <li>Bernstein Research: \"There is evidence from Starz that losing Disney movie output doesn't necessarily have any visible impact on subscriber growth, as long as the entirety of the service is a good value proposition to consumers.\"</li><li>Raymond James: \"Netflix is still a global share gain story that is benefiting from its original content strategy.\"</li> <li>Sources: <a href=\"http://www.multichannel.com/news/content/losing-disney-movies-may-not-hurt-netflix-analyst/414488\" target=\"_blank\">Multichannel News</a> and <a href=\"http://www.barrons.com/articles/netflix-disney-cuts-the-cord-a-modest-but-manageable-negative-1502286966\" target=\"_blank\">Barron's</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3286983-disney-pulls-plug-netflix\" target=\"_blank\">Disney pulls the plug on Netflix</a> (Aug. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286989-disney-taking-bamtech-launch-espn-disney-streaming-services\" target=\"_blank\">Disney taking over BAMTech; to launch ESPN, Disney streaming services</a> (Aug. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287592\" data-linked=\"Analysts unflustered over loss of Disney content at Netflix\" data-tweet=\"$NFLX - Analysts unflustered over loss of Disney content at Netflix https://seekingalpha.com/news/3287592-analysts-unflustered-over-loss-of-disney-content-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3287592-analysts-unflustered-over-loss-of-disney-content-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287590\" data-ts=\"1502290144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CROX\" target=\"_blank\">CROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287590-on-crocs-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Crocs&#39; Q2</a></h4><ul>     <li>Crocs (<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='green'>+5.4%</font>)&nbsp;reports revenue declined 2.7% on a constant&nbsp;currency basis in <a href=\"https://seekingalpha.com/pr/16910937-crocs-inc-reports-second-quarter-2017-results\" target=\"_blank\">Q2</a>.</li>     <li>Total wholesale revenue fell 7.3% to $153.M.</li>     <li>Total retail revenue down 4.4% to $108.08M.</li>     <li>Total e-commerce revenue rose 14.5% to $51.64M.</li>     <li>Gross margin rate improved 180 bps to 54.2%.</li>     <li>SG&amp;A expense rate -120 bps to 44.8%.</li>     <li>Store count was 503 for the quarter.</li>     <li><strong>Q3 Guidance</strong>: Revenues: $230M to $240M; Gross margin rate: flat; SG&amp;A expense: down ~$3M.</li>     <li><strong>FY2018 Guidance</strong>: Revenues:&nbsp;down low single digits; Gross margin rate: ~50%; SG&amp;A expense: $490M to $495M.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3287590\" data-linked=\"More on Crocs&#39; Q2\" data-tweet=\"$CROX - More on Crocs&#39; Q2 https://seekingalpha.com/news/3287590-on-crocs-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3287590-on-crocs-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287589\" data-ts=\"1502290027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALB\" target=\"_blank\">ALB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287589-albemarle-extends-losses-cost-of-finding-lithium-seen-rising\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albemarle extends losses as cost of finding lithium seen rising</a></h4><ul>     <li>Albemarle (<a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='red'>-2.5%</font>) extends yesterday's 6% loss - the stock's worst one-day drop in a year and a half - after warning that <a href=\"https://www.bloomberg.com/news/articles/2017-08-08/albemarle-drops-most-on-s-p-500-as-cost-of-finding-lithium-rises\" target=\"_blank\">weaker lithium prices will weigh on earnings</a> for the rest of the year.</li>     <li>Lithium profits for the remainder of 2017 likely will decline from <a href=\"https://seekingalpha.com/news/3286533-albemarle-beats-0_02-beats-revenue\" target=\"_blank\">Q2's</a> record level, CFO Scott Tozier said during yesterday's <a href=\"https://seekingalpha.com/article/4096680-albemarles-alb-ceo-luke-kissam-q2-2017-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>, suggesting earnings may fall short of analyst expectations in H2.</li>     <li>But &ldquo;the long-term secular growth rate in lithium continues to strengthen as evidenced by increasing targets across the automotive industry and the global effort for governments to support the transition to electric vehicles,&rdquo; CEO&nbsp;Luke Kissam said.</li>     <li>Lithium prices for the company should still rise 20% for the year, following Q2's 31% increase, ALB said.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287589\" data-linked=\"Albemarle extends losses as cost of finding lithium seen rising\" data-tweet=\"$ALB - Albemarle extends losses as cost of finding lithium seen rising https://seekingalpha.com/news/3287589-albemarle-extends-losses-cost-of-finding-lithium-seen-rising?source=tweet\" data-url=\"https://seekingalpha.com/news/3287589-albemarle-extends-losses-cost-of-finding-lithium-seen-rising\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287588\" data-ts=\"1502290024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287588-acadia-up-18-on-q2-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACADIA up 18% on Q2 beat</a></h4><ul><li>ACADIA Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='green'>+17.5%</font>) heads north on more than double normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/16910370-acadia-pharmaceuticals-reports-second-quarter-2017-financial-results\" target=\"_blank\">Q2 results</a> released after the close yesterday.</li><li>Nuplazid sales continue to ramp, up almost 100% sequentially (includes $3.6M associated with the change in accounting treatment to sell-in revenue recognition from sell-through method) and up 154% since Q4 2016.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286982-acadia-pharma-beats-0_17-beats-revenue\" target=\"_blank\">ACADIA Pharma beats by $0.17, beats on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287588\" data-linked=\"ACADIA up 18% on Q2 beat\" data-tweet=\"$ACAD - ACADIA up 18% on Q2 beat https://seekingalpha.com/news/3287588-acadia-up-18-on-q2-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3287588-acadia-up-18-on-q2-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287585\" data-ts=\"1502289336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRA\" target=\"_blank\">NTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287585-q2-beat-propels-natera-up-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Q2 beat propels Natera, up 30%</a></h4><ul><li>Thinly traded Natera (<a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a> <font color='green'>+30.4%</font>) is up in early trading on a 44% surge in volume, albeit on turnover of only 256K shares, after posting <a href=\"https://seekingalpha.com/pr/16910394-natera-reports-second-quarter-2017-financial-results\" target=\"_blank\">Q2 results</a>&nbsp;after the close yesterday that beat consensus.</li><li>Revenues were up 3% to $53.6M despite the transition of most of its revenue to in-network payer contracts.</li><li>It processed 125.7K tests, up 21%.</li><li><strong>2017 Guidance</strong>: Revenue: $210M - 230M, cash consumption: $65M - 75M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287086-natera-beats-0_02-beats-revenue\" target=\"_blank\">Natera beats by $0.02, beats on revenue</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287585\" data-linked=\"Q2 beat propels Natera, up 30%\" data-tweet=\"$NTRA - Q2 beat propels Natera, up 30% https://seekingalpha.com/news/3287585-q2-beat-propels-natera-up-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3287585-q2-beat-propels-natera-up-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287586\" data-ts=\"1502289072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KELYA\" target=\"_blank\">KELYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287586-on-kelly-services-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Kelly Services&#39; Q2</a></h4><ul>     <li>Kelly Services (<a href='https://seekingalpha.com/symbol/KELYA' title='Kelly Services, Inc.'>KELYA</a> <font color='green'>+4.2%</font>)&nbsp;reports revenue slipped 2.7% on a constant&nbsp;currency basis in <a href=\"https://seekingalpha.com/pr/16911040-kelly-services-r-reports-second-quarter-earnings\" target=\"_blank\">Q2</a>.</li>     <li>Total Americas revenue from services rose 3.8% to $1.06B (+3.8%&nbsp;on a constant currency basis).</li>     <li>Total EMEA revenue from services grew 7.1% to $265.8M (+8.7%&nbsp;on a constant currency basis).</li>     <li>Gross margin rate improved 40 bps to 17.2%.</li>     <li>SG&amp;A expense rate -40 bps to 15.6%.</li>     <li>Operating margin rate advanced 80 bps to 1.5%.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3287586\" data-linked=\"More on Kelly Services&#39; Q2\" data-tweet=\"$KELYA - More on Kelly Services&#39; Q2 https://seekingalpha.com/news/3287586-on-kelly-services-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3287586-on-kelly-services-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287584\" data-ts=\"1502289054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287584-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-6.5M</strong> barrels vs. -2.7M consensus, -1.5M last week.</li>     <li>Gasoline <strong>+3.4</strong><strong>M</strong> barrels vs. -1.5M consensus, -2.5M last week.</li>     <li>Distillates <strong>-1.7M</strong> vs. -0.1M consensus, -0.2M last week.</li>     <li>Futures<font color='green'> +0.65%</font>&nbsp;to $49.49.</li>     <li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3287584\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3287584-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3287584-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287583\" data-ts=\"1502288988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVI\" target=\"_blank\">CVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287583-reuters-investors-build-big-short-position-in-icahns-cvr-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Investors build big short position in Icahn&#39;s CVR Energy</a></h4><ul>     <li>Investors have <a href=\"http://www.reuters.com/article/us-icahn-biofuels-cvr-idUSKBN1AP17G?il=0\" target=\"_blank\">built up a large short position</a> in Carl Icahn's CVR Energy (<a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color='red'>-1.6%</font>) oil refiner, according to Reuters data, as the company's gamble on the biofuels market appears to have turned sour.</li>     <li>CVI, in which Icahn holds an 82% stake, had ~6.5% short interest overall as of mid-July, up from 5.2% at the end of March, which would translate to about one third of the stock not held by Icahn being borrowed by investors betting the company's value will decline.</li>     <li>CVI last year deferred $186M worth of biofuels credits that it was required to purchase under the Renewable Fuel Standard regulation in an apparent bet that prices would fall within 12 months, and this year continued to build the position to $275M-plus, but RIN prices have nearly tripled since March; Icahn, a friend an special adviser to Pres. Trump, also appears to have failed in his efforts to change the policy to lift the blending  burden from refiners.</li><li>Also: <a href='https://seekingalpha.com/symbol/CVRR' title='CVR Refining, LP'>CVRR</a> <font color='red'>-2.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3287583\" data-linked=\"Reuters: Investors build big short position in Icahn&#39;s CVR Energy\" data-tweet=\"$CVI $CVI $CVRR - Reuters: Investors build big short position in Icahn&#39;s CVR Energy https://seekingalpha.com/news/3287583-reuters-investors-build-big-short-position-in-icahns-cvr-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3287583-reuters-investors-build-big-short-position-in-icahns-cvr-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287581\" data-ts=\"1502288901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STWD\" target=\"_blank\">STWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287581-starwood-property-up-2-after-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starwood Property up 2% after Q2 results</a></h4><ul><li>Q2 core earnings of $136.8M or $0.52 per share vs. $131.8M and $0.51 a year ago. Dividend is $0.48.</li><li>$1.5B put to work during Q2, including $871M of floating-rate loan originations. $1.4B put to work in Q1, including $930M of floating-rate loans.</li><li>Portfolio LTV remains at just under 63%.</li><li>Shortly after quarter's end, company expanded access to reasonably priced capital with membership in the FHLB of Chicago. Also Ten-X (formerly auction.com) entered into a strategic deal which should allow harvesting of significant embedded value on balance sheet in Q3.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287333-starwood-property-trust-beats-0_01-misses-revenue\" target=\"_blank\">Starwood Property Trust beats by $0.01, misses on revenue</a> (Aug. 9)</li><li><a href='https://seekingalpha.com/symbol/STWD' title='Starwood Property Trust, Inc.'>STWD</a><font color='green'> +2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3287581\" data-linked=\"Starwood Property up 2% after Q2 results\" data-tweet=\"$STWD - Starwood Property up 2% after Q2 results https://seekingalpha.com/news/3287581-starwood-property-up-2-after-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3287581-starwood-property-up-2-after-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287579\" data-ts=\"1502288754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BUFF\" target=\"_blank\">BUFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287579-blue-buffaloplus-10-after-full-year-guidance-satisfies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Buffalo +10% after full-year guidance satisfies</a></h4><ul> <li>Blue Buffalo (NASDAQ:<a href='https://seekingalpha.com/symbol/BUFF' title='Blue Buffalo'>BUFF</a>) rips a <font color='green'>10% post-earnings gain</font> after the company's full-year of guidance $1.24B to $1.27B tops the consensus estimate of $1.24B. A new $50M buyback progrma from Blue Buffalo may also be capturing the attention of investors.</li> <li>The company was also added to the analyst focus list at JPMorgan and mentioned favorably at Susquehanna.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286962-blue-buffalo-eps-line-misses-revenue\" target=\"_blank\">Blue Buffalo EPS in-line, misses on revenue</a> (Aug. 8)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3287579\" data-linked=\"Blue Buffalo +10% after full-year guidance satisfies\" data-tweet=\"$BUFF - Blue Buffalo +10% after full-year guidance satisfies https://seekingalpha.com/news/3287579-blue-buffaloplus-10-after-full-year-guidance-satisfies?source=tweet\" data-url=\"https://seekingalpha.com/news/3287579-blue-buffaloplus-10-after-full-year-guidance-satisfies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287573\" data-ts=\"1502288386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBLI\" target=\"_blank\">CBLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287573-cleveland-biolabs-up-6-on-rumored-entolimod-dod-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland BioLabs up 6% on rumored entolimod DoD contract</a></h4><ul><li>Thinly traded nano cap Cleveland BioLabs (<a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='green'>+6.2%</font>) perks up on more than triple normal volume, albeit on turnover of only 187K shares, on rumors about a new contract with the U.S. Department of Defense (DoD) related to radiation countermeasure <a href=\"http://www.cbiolabs.com/entolimod-cblb502-biodefense/\" target=\"_blank\">entolimod</a>.</li><li>The DoD awarded the company a $9.2M contract two years ago to support development, specifically funding pivotal animal studies to support a BLA filing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2759306-cleveland-bio-snags-9_2m-dod-contract-develop-entolimod\" target=\"_blank\">Cleveland Bio snags $9.2M DoD contract to develop entolimod</a> (Sept. 2, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287573\" data-linked=\"Cleveland BioLabs up 6% on rumored entolimod DoD contract\" data-tweet=\"$CBLI - Cleveland BioLabs up 6% on rumored entolimod DoD contract https://seekingalpha.com/news/3287573-cleveland-biolabs-up-6-on-rumored-entolimod-dod-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3287573-cleveland-biolabs-up-6-on-rumored-entolimod-dod-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287576\" data-ts=\"1502288319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STS\" target=\"_blank\">STS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287576-wabash-national-buys-out-supreme-industries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wabash National buys out Supreme Industries</a></h4><ul>          <li>Supreme Industries (<a href='https://seekingalpha.com/symbol/STS' title='Supreme Industries, Inc'>STS</a> <font color='green'>+35.4%</font>) agrees to be acquired by Wabash National Corporation (<a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='green'>+2.5%</font>)&nbsp;in a transaction valued       at approximately $364M.</li>     <li>Under the terms of the agreement, Supreme shareholders receive       $21.00 per share.</li>     <li>\"This is a great opportunity for both companies to combine our strengths       to provide an enhanced customer experience within the growing final mile       delivery space,\" says Wabash CEO&nbsp;Dick Giromini.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16910732-supreme-industries-enters-agreement-acquired-21_00-per-share\" target=\"_blank\">Press Release</a></li>      </ul><div class=\"tiny-share-widget\" data-id=\"3287576\" data-linked=\"Wabash National buys out Supreme Industries\" data-tweet=\"$STS $STS $WNC - Wabash National buys out Supreme Industries https://seekingalpha.com/news/3287576-wabash-national-buys-out-supreme-industries?source=tweet\" data-url=\"https://seekingalpha.com/news/3287576-wabash-national-buys-out-supreme-industries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287571\" data-ts=\"1502287745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTN\" target=\"_blank\">RTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287571-korea-tensions-put-defense-sector-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Korea tensions put defense sector in focus</a></h4><ul><li>Gains are being seen across the defense sector as President Trump <a href=\"https://seekingalpha.com/news/3287274-north-korea-tensions-shake-markets\" target=\"_blank\">warned</a> that North Korean aggression would be \"met with fire and fury,\" but the advance appears limited, with Secretary of State Tillerson <a href=\"https://apnews.com/931769550f3b433ca64f6c5e633da23b\" target=\"_blank\">insisting</a> there wasn't \"any imminent threat.\"</li><li>In early trade: <a href='https://seekingalpha.com/symbol/RTN' title='Raytheon Company'>RTN</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color='green'>+1%</font>, <a href='https://seekingalpha.com/symbol/LLL' title='L3 Technologies'>LLL</a> <font color='green'>+0.9%</font>, <a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color='green'>+0.8%</font>, <a href='https://seekingalpha.com/symbol/GD' title='General Dynamics Corporation'>GD</a> <font color='green'>+0.3%</font>, <a href='https://seekingalpha.com/symbol/HII' title='Huntington Ingalls Industries, Inc.'>HII</a> <font color='green'>+0.2%</font>, <a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a> <font color='green'>+0.2%</font>, <a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc'>AJRD</a> <font color='green'>+0.2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3287571\" data-linked=\"Korea tensions put defense sector in focus\" data-tweet=\"$RTN $RTN $LMT - Korea tensions put defense sector in focus https://seekingalpha.com/news/3287571-korea-tensions-put-defense-sector-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/3287571-korea-tensions-put-defense-sector-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287570\" data-ts=\"1502287707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287570-teva-accelerates-asset-sales-to-cut-debt-preserve-credit-rating-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva accelerates asset sales to cut debt, preserve credit rating - Bloomberg</a></h4><ul><li>Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2017-08-09/teva-is-said-to-ramp-up-asset-sales-with-medis-respiratory-unit\" target=\"_blank\">reports</a> that Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-0.8%</font>) is ramping up asset sales in order to preserve its credit rating and pay down debt.</li><li>Candidates include Medis, an Iceland-based firm that develops generics for other companies, and some of its respiratory assets.</li><li>Medis could fetch $500M - $1B while the respiratory business could be valued as high as $2B, depending on which treatments are included and the value given to the pipeline.</li><li>The company aims to cut its business-choking level of debt which totaled ~$35B at the end of June.</li></ul><div class=\"tiny-share-widget\" data-id=\"3287570\" data-linked=\"Teva accelerates asset sales to cut debt, preserve credit rating - Bloomberg\" data-tweet=\"$TEVA - Teva accelerates asset sales to cut debt, preserve credit rating - Bloomberg https://seekingalpha.com/news/3287570-teva-accelerates-asset-sales-to-cut-debt-preserve-credit-rating-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3287570-teva-accelerates-asset-sales-to-cut-debt-preserve-credit-rating-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>159&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3287563\" data-ts=\"1502286861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3287563-generic-drug-firms-under-pressure-after-soft-guidance-from-mylan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Generic drug firms under pressure after soft guidance from Mylan</a></h4><ul><li>Most generic drug makers are underwater in early trading on the heels of Mylan's (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-4.9%</font>) Q2 report. The numbers looked good, but the company admitted pricing headwinds and lowered its non-GAAP EPS guidance.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color='red'>-2%</font>)(<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='red'>-1.6%</font>)(IPXL <font color='green'>+7.3%</font>)(<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='red'>-3.4%</font>)(VRX <font color='red'>-4.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3287563\" data-linked=\"Generic drug firms under pressure after soft guidance from Mylan\" data-tweet=\"$MYL $MYL $TEVA - Generic drug firms under pressure after soft guidance from Mylan https://seekingalpha.com/news/3287563-generic-drug-firms-under-pressure-after-soft-guidance-from-mylan?source=tweet\" data-url=\"https://seekingalpha.com/news/3287563-generic-drug-firms-under-pressure-after-soft-guidance-from-mylan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}